Etiology, Epidemiology, Pathogenesis, and Clinical Insights of Rabies

Abstract

Rabies remains a global health concern in the 21st century, even with the constant attention it receives from scholars and scientists. This report provides a comprehensive overview of the disease by exploring its etiology, epidemiology, pathogenesis, clinical manifestations, treatment options, and prevention strategies. It is a zoonotic disease transmitted through a scratch or bite from an infected mammal. Usually, dogs are the most common vector, with literature linking it with the disease. The virus is highly neurotropic because it rapidly invades the central nervous system. Analysis of the epidemiological burden of the disease reveals its substantial impacts. It causes up to 59,000 human deaths annually (Pieracci et al., 2019). However, there is a disproportionate impact on regions with adequate access to post-exposure prophylaxis. Its pathogenesis relies on the ability to invade the peripheral nerves and the central nervous system. This results in neurological symptoms in the victim of a bite or scratch from a mammal with rabies. Early intervention in this disease is challenging because the clinical diagnosis not only depends on the presence of neurological but also knowledge of the history of animal exposure. Effectiveness in the management of the disease relies on post-exposure prophylaxis. This involves administering a rabies vaccine and immune globulin after exposure. Even so, the management is difficult because once the clinical symptoms manifest, the disease is nearly fatal. Some of the prevention strategies include vaccinating domestic animals, public awareness, and control of stray dog populations. Rabies highlights and serves as a reminder of timely intervention and the need for effective preventive measures. For this reason, it is necessary to study the scope of the disease and determine ways to enhance vaccination coverage and international cooperation.

1. Introduction

Rabies is a viral disease that affects both humans and mammals. This zoonotic disease is characterised by its ability to target the central nervous system. It results in fatal encephalitis and other effects on the brain. This report aims to conduct an extensive analysis of the scope of this disease. It is concerned with different aspects such as its origin, prevalence, and biological processes involved with the infection. Besides, it also explores the clinical signs it presents, available treatment, and preventive strategies that address the virus. This will offer a background for linking different factors associated with the disease. A comprehensive understanding of the disease helps better the strategies for addressing its consequences.

2. Findings and Discussion

2.1. Aetiology

Rabies is a disease caused by the Rabies virus, which is a member of the lyssavirus genus and Rhabdoviridae family (Shepherd et al., 2023). The virus has an innate predilection for the nerve cells, making its impacts significant to the central nervous system. The virus enters the body when an infected animal scratches or bites a human or another animal. Usually, this is likely to occur in an area where there is minimum vaccination coverage for the virus. After entering the body at the site of the bite or scratch, the virus binds to acetylcholine receptors in muscle cells. It begins its replication before advancing through the peripheral nerves. The virus utilises the microtubules as a highway to the central nervous system, as illustrated in Figure I. One of its unique features is the ability to exploit the retrograde axonal transport that takes it through the spiral cord to the brain.

Figure 1: Rabies Virus Journey at Entry

At the central nervous system, the rabies virus induces a robust immune response. It triggers inflammation in the brain that leads to encephalitis. This leads to neuronal damage, causing the characteristic symptoms of rabies that may result in extreme life-threatening clinical manifestations for individuals with the virus (Smith et al., 2023). A comprehensive understanding of the complex etiology of rabies is crucial because it highlights the neurotrophic nature of the virus that prompts timely intervention. Post-exposure prophylaxis is one alternative that helps block progression to the nervous system. It is integral in exploring effective strategies that prevent the entry and spread of the virus within human and animal populations.

2.2. Epidemiology

Further analysis of the disease indicates that it remains a significant problem that causes distress in global public health. Annual records indicate that it causes up to 59,000 deaths (Pieracci et al., 2019). Notably, the concern is aggravated by reports that such an impact is unevenly distributed. A bigger proportion of the fatalities from the disease are reported in Africa and Asia. The burden of rabies in these regions is accounted for by the high prevalence of the virus in the local animal population in the localities. These areas also have limited access to life-saving approaches that help create post-exposure prophylaxis. There is a lack of comprehensive dog vaccination programs in these areas.

The main mode of transmission in these regions and high prevalence is linked with dog bites. This is because dogs are usually unvaccinated, making them vectors with humans. Prevalence is much higher in the local areas of these regions, leading to higher incidences of rabies exposure. According to Lodha et al. (2023), it is challenging to implement “current strategies of canine immunisation, sterilisation, and providing post-exposure prophylaxis to exposed individuals” (p. 258). Such statistics and reports highlight the need for addressing rabies from both animal and human health perspectives. In order to successfully mitigate the risk of rabies infection, it is necessary to implement widespread dog vaccination campaigns. Areas that are rabies endemic should have high access to post-exposure prophylaxis. These findings emphasised the importance of making coordinated efforts to reduce the human toll of this zootic disease.

2.3. Clinical Symptoms

The clinical symptoms of rabies are both devastating and distinctive. In the earlier stages of the disease of a bite or scratch, the patient is infected with the virus. The symptoms are usually non-specific, including localised pain at the site of the bite. Some individuals may also have fever and malaise. However, these symptoms may transform into devastating cases over time (Ferdaouss et al., 2023). This occurs when the virus invades the central nervous system, leading to neurological disturbances. Most of the symptoms after the invasion include anxiety, confusion, and agitation. Severe symptoms of the disease occur when the disease advances further. For example, hallucinations that are terrifying and vivid are the ultimate sign of rabies. They also play a role in aggravating the distress and anxiety of an infected individual.

Extreme cases result in paralysis that kicks in after hallucinations. Commonly, this occurs starting from the site of the bite before progressing to other muscle groups. Aerophobia is another symptom of this disease that leads to a painful fear of swallowing liquids (Dorji et al., 2023). This irrational sign is caused by throat muscle spasms that make the sight of water and other liquids unbearable. Noteworthy, these clonal signs are invaluable in the absence of direct laboratory testing during diagnosis. This necessitates the need for a history of animal exposure, including recent bites. Successfully identifying any history will help justify the development of neurological symptoms. Therefore, it forms a critical basis for clinical diagnoses to have prior information of a potential victim. Table 1 summarises clinical symptoms associated with rabies and details brief descriptions of the signs.

3. Conclusion

In conclusion, this comprehensive report on rabies highlights the gravity of this zoonotic disease. It continues to exert a significant global toll by affecting vulnerable regions with limited access to preventive measures. The pathogenesis reveals the virus’s neurotropic nature, highlighting the urgency of timely post-exposure prophylaxis. Epidemiologically, Asia and Africa bear the brunt of rabies, emphasizing the necessity for improved vaccination and awareness programs. Clinical symptoms, while distinctive and devastating, often serve as a basis for diagnosis, yet the limited treatment options underline the critical importance of prevention. Based on these findings, it is evident that rabies remains a significant concern and a global health challenge. In order to combat this menace effectively, further research is essential. It should explore ways to focus on the development of innovative treatments, expanded access to post-exposure prophylaxis, and improved vaccination coverage.

References

Dorji, T., Lamichaney, J., Gyaltshen, C., Lungten, L., Dhakal, G. P., Dorjee, S., & Mynak, M. L. (2023). Human rabies encephalomyelitis in the background of rabies outbreak in animals in Gelephu, Bhutan, 2023: a case report. Infectious Diseases of Poverty, 12(1). https://doi.org/10.1186/s40249-023-01148-2.

Ferdaouss, Q., Boujraf, S., Ismail, C., Rim, E. A., Amine, B., Chadya, A., & Rachid, A. (2023). Rabies infection recognized as a psychosis: A misleading psychiatric presentation. Journal of Neurosciences in Rural Practice, 14(541), 541–543. https://doi.org/10.25259/jnrp_20_2023.

Pieracci, E. G., Pearson, C. M., Wallace, R. M., Blanton, J. D., Whitehouse, E. R., Ma, X., Stauffer, K., Chipman, R. B., & Olson, V. (2019). vital signs: trends in human rabies deaths and exposures — United States, 1938–2018. MMWR. Morbidity and Mortality Weekly Report, 68(23), 524–528. https://doi.org/10.15585/mmwr.mm6823e1.

Shepherd, J. G., Davis, C., Streicker, D. G., & Thomson, E. C. (2023). Emerging rhabdoviruses and human infection. Biology, 12(6), 878. https://doi.org/10.3390/biology12060878.

Smith, S. P., Shipley, R., Drake, P., Fooks, A. R., Ma, J., & Banyard, A. C. (2023). Characterisation of a live-attenuated rabies virus expressing a secreted scFv for the treatment of rabies. Viruses, 15(8), 1674. https://doi.org/10.3390/v15081674.

Nyasulu, P. S., Weyer, J., Tschopp, R., Mihret, A., Aseffa, A., Nuvor, S. V., Tamuzi, J. L., Nyakarahuka, L., Helegbe, G. K., Ntinginya, N. E., Gebreyesus, M. T., Doumbia, S., Busse, R., & Drosten, C. (2021). Rabies mortality and morbidity associated with animal bites in Africa: a case for integrated rabies disease surveillance, prevention and control: a scoping review. BMJ open, 11(12), e048551. https://doi.org/10.1136/bmjopen-2020-048551

Amoako, Y. A., El-Duah, P., Sylverken, A. A., Owusu, M., Yeboah, R., Gorman, R., Adade, T., Bonney, J., Tasiame, W., Nyarko-Jectey, K., Binger, T., Corman, V. M., Drosten, C., & Phillips, R. O. (2021). Rabies is still a fatal but neglected disease: A case report. Journal of Medical Case Reports, 15(1), 575. https://doi.org/10.1186/s13256-021-03164-y